Magnesium sulfate infusion for acute asthma in the emergency department
Journal Title: Jornal de Pediatria - Year 2017, Vol 93, Issue 0
Abstract
Objectives To describe the role of intravenous magnesium sulfate (MgSO4) as therapy for acute severe asthma in the pediatric emergency department (ED). Source Publications were searched in the PubMed and Cochrane databases using the following keywords: magnesium AND asthma AND children AND clinical trial. A total of 53 publications were retrieved using this criteria. References of relevant articles were also screened. The authors included the summary of relevant publications where intravenous magnesium sulfate was studied in children (age <18 years) with acute asthma. The NAEPP and Global Initiative for Asthma expert panel guidelines were also reviewed. Summary of the data There is a large variability in the ED practices on the intravenous administration of MgSO4 for severe asthma. The pharmacokinetics of MgSO4 is often not taken into account with a consequent impact in its pharmacodynamics properties. The cumulative evidence points to the effectiveness of intravenous MgSO4 in preventing hospitalization, if utilized in a timely manner and at an appropriate dosage (50–75mg/kg). For every five children treated in the ED, one hospital admission could be prevented. Another administration modality is a high-dose continuous magnesium sulfate infusion (HDMI) as 50mg/kg/h/4h (200mg/kg/4h). The early utilization of HDMI for non-infectious mediated asthma may be superior to a MgSO4 bolus in avoiding admissions and expediting discharges from the ED. HDMI appears to be cost-effective if applied early to a selected population. Intravenous MgSO4 has a similar safety profile than other asthma therapies. Conclusions Treatment with intravenous MgSO4 reduces the odds of hospital admissions. The use of intravenous MgSO4 in the emergency room was not associated with significant side effects or harm. The authors emphasize the role of MgSO4 as an adjunctive therapy, while corticosteroids and beta agonist remain the primary acute therapeutic agents.
Authors and Affiliations
Jose Enrique Irazuzta
Keywords
Related Articles
- EP ID EP503411
- DOI 10.1016/j.jped.2017.06.002
- Views 54
- Downloads 0
The association of sleep and late-night cell phone use among adolescents
Objective This study aims to assess the relationship of late-night cell phone use with sleep duration and quality in a sample of Iranian adolescents. Methods The study population consisted of 2400 adolescents, aged 12–1...
Prevalence and factors associated with stunting and excess weight in children aged 0-5 years from the Brazilian semi-arid region
Objective To analyze the prevalence of excess weight and low height, and identify associated factors among children younger than five years. Methods Cross-census study. A total of 1,640 children from two municipalities...
Maternal food intake and socioeconomic status to tackle childhood malnutrition
This issue features a study by Géa-Horta et al.,1 which describes the association between maternal socioeconomic factors (employment and level of schooling) and the occurrence of some nutritional indicators (short statur...
Association of junk food consumption with high blood pressure and obesity in Iranian children and adolescents: the CASPIAN-IV Study
Objective This study aimed to evaluate the association of junk food consumption with hypertension and obesity in a national sample of Iranian children and adolescents. Methods This nationwide study was conducted in 2011...
The protective arm of the renin–angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves
Objective Posterior urethral valve is the most common lower urinary tract obstruction in male children. A high percentage of patients with posterior urethral valve evolve to end-stage renal disease. Previous studies show...